Cargando…
Omega-3 Fatty Acids as a Treatment for Pediatric Depression. A Phase III, 36 Weeks, Multi-Center, Double-Blind, Placebo-Controlled Randomized Superiority Study
Background: Depressive disorders in childhood and adolescence are a major health problem and often follow a chronic course with severe consequences in later life. Depressive disorders cause the highest burden of disease in this age group across all medical conditions. Treatment adherence is usually...
Autores principales: | Häberling, Isabelle, Berger, Gregor, Schmeck, Klaus, Held, Ulrike, Walitza, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892434/ https://www.ncbi.nlm.nih.gov/pubmed/31827448 http://dx.doi.org/10.3389/fpsyt.2019.00863 |
Ejemplares similares
-
Deficient prefrontal-amygdalar connectivity underlies inefficient face processing in adolescent major depressive disorder
por: Willinger, David, et al.
Publicado: (2022) -
Efficacy and Safety of Cordyceps militaris as an Adjuvant to Duloxetine in the Treatment of Insomnia in Patients With Depression: A 6-Week Double- Blind, Randomized, Placebo-Controlled Trial
por: Zhou, Jiaojiao, et al.
Publicado: (2021) -
Omega-3 for the Prevention of Alcohol Use Disorder Relapse: A Placebo-Controlled, Randomized Clinical Trial
por: Pauluci, Renata, et al.
Publicado: (2022) -
Verbal Memory Performance in Depressed Children and Adolescents: Associations with EPA but Not DHA and Depression Severity
por: Emery, Sophie, et al.
Publicado: (2020) -
Development and reliability of the coding system evaluating maternal sensitivity to social interactions with 34- to 36-week postmenstrual age preterm infants
por: Boissel, Laure, et al.
Publicado: (2022)